Skip to main content

JAGSNPHARM · Jagsonpal Pharmaceuticals Limited · Documents

216.05 INR -1.50 (-0.69%) At close · Nov 13
Volume · Nov 13 2508 Avg daily vol (3M) 12.61K

The company's reports, filings, earnings calls and investor events, most recent first. Search these from Claude or ChatGPT →

Earnings call Q2 2027 earnings call Held Oct 29, 2026
2026
Oct 29
Earnings call
Q2 2027 earnings call

Jaxampal Pharmaceuticals Ltd. reported organic growth of 9.3%, H1 EBITDA margin of 22.9% and cash and bank balance of 135 crores. It targets Rs. 500 crore by FI 2028 and Q3 revenue crossing 100 crores with consolidated EBITDA margin above 22%.

Showing 1–3 of 3 documents